FDA OKs Nivolumab After Surgery for Esophageal or GEJ Cancer ...Middle East

Medscape - News
The adjuvant use of nivolumab has been described as practice-changing in patients with resected esophageal or gastroesophageal junction cancer who have received chemoradiotherapy before surgery. FDA Approvals

Hence then, the article about fda oks nivolumab after surgery for esophageal or gej cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA OKs Nivolumab After Surgery for Esophageal or GEJ Cancer )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News